MiMedx Group, Inc. Increase (Decrease) in Other Current Assets
MiMedx Group, Inc. (MDXG) reported Increase (Decrease) in Other Current Assets of -$675.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2022-02-28
- MiMedx Group, Inc. increase (decrease) in other current assets for the quarter ending 2020-03-31 was -$812.00K, a 150.37% decline year-over-year.
- MiMedx Group, Inc. increase (decrease) in other current assets for the quarter ending 2019-12-31 was $2.25M.
- MiMedx Group, Inc. increase (decrease) in other current assets for the quarter ending 2019-03-31 was $1.61M.
- MiMedx Group, Inc. increase (decrease) in other current assets for the quarter ending 2018-12-31 was -$2.71M.
- MiMedx Group, Inc. increase (decrease) in other current assets for fiscal 2021 was -$675.00K, a 667.23% decline from fiscal 2020.
- MiMedx Group, Inc. increase (decrease) in other current assets for fiscal 2020 was $119.00K, a 97.94% decline from fiscal 2019.
- MiMedx Group, Inc. increase (decrease) in other current assets for fiscal 2019 was $5.77M.
- MiMedx Group, Inc. increase (decrease) in other current assets for fiscal 2018 was -$3.56M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | -$675.00K 10-K · filed 2022-02-28 | ||||
| 2020-12-31 | $119.00K 10-K · filed 2022-02-28 | ||||
| 2020-03-31 | -$812.00K 10-Q · filed 2020-07-06 | $1.44M derived: sum of 2 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.77M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $3.52M 10-Q · filed 2020-07-06 | ||||
| 2019-03-31 | $1.61M 10-Q · filed 2020-07-06 | -$1.09M derived: sum of 2 quarters · filed 2021-03-08 | |||
| 2018-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$3.56M 10-K · filed 2021-03-08 | |||
| 2018-09-30 | -$855.00K 10-Q · filed 2020-07-06 | ||||
| 2017-12-31 | -$225.00K 10-K · filed 2020-07-06 | ||||
| 2016-12-31 | $1.57M 10-K · filed 2020-03-17 | $384.00K 10-K · filed 2017-03-01 | |||
| 2015-12-31 | $240.00K 10-K · filed 2017-03-01 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |